Oral vs IV antibiotics for liver abscess treatment
Part of Digestive system, Infections clinical trials.
This trial compares two antibiotic treatments for liver abscess: one given through an IV (into a vein) and one taken as pills by mouth. The goal is to see if the oral treatment works just as well, which could make treatment easier and more convenient for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a liver abscess confirmed by a CT scan or ultrasound.
- You are 18 years or older.
- You have no past history of liver abscess.
- You do not have chronic kidney disease.
- You are not allergic to metronidazole, cefixime, or beta-lactam antibiotics.
- You are not pregnant, not on blood thinners, and can take medications by mouth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how liver abscesses are treated and how well they heal. It includes people whose abscess was found on a scan and drained, and who got better with antibiotics.
This study compares two strong antibiotics—ceftazidime-avibactam and a high dose of meropenem given over a longer infusion—in patients with advanced liver disease who develop a hospital-acquired infection. The goal is to see which works better and is safer.
This trial looks at whether continuing treatment for a bacterial brain abscess using partially oral antibiotics works as well as the usual approach. It may help people who have already had 14 days of antibiotic treatment and are stable enough to take medicines by mouth.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
This study compares two ways of giving preventive antibiotics to liver transplant patients who carry resistant bacteria. The goal is to see if targeted antibiotics work better than standard ones at preventing infections without causing more side effects.
This trial compares starting antibiotics through a vein (IV) to taking them by mouth for common infections like pneumonia, urinary tract infections, or skin infections (cellulitis). The goal is to see if oral antibiotics work just as well without the need for an IV line.
Hear when a new Liver Abscess trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.